A live She Leads Biotech podcast featuring industry leaders discussing leadership journeys, career growth and the evolving role of women in biotech.

A new model for biotech funding. Nicole Paulk explains how Siren Biotechnology’s crowdfunding strategy is engaging the public and reshaping investment.

A powerful closing keynote on challenging broken systems in rare disease and how patient-led innovation can drive real breakthroughs.

Ensuring AAV vector safety. This session explores unbiased assays for detecting rcAAV, improving sensitivity, reproducibility and regulatory confidence.

Clinical insights from CARTITUDE studies. Explore biomarkers linked to durable response in patients with relapsed or refractory multiple myeloma.

Innovative biotech start-ups pitch breakthrough ideas to leading investors, gaining real-time feedback on science, strategy and funding potential.

Advanced therapies need infrastructure to scale. Leaders explore the lab and manufacturing space bottleneck shaping biotech growth and investment.

How translational centers accelerate CGT development. Sarah Callens shares lessons from enabling biotech teams to move from IND to GMP readiness.

Early regulatory engagement can make or break CGT programs. Experts discuss strategies for aligning data, trials and communication with regulators.

How patient advocacy is shaping early clinical development. Experts discuss aligning trial design, endpoints and engagement with real patient needs.